Benzinga | Jul 30, 2021 07:30AM EDT

Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Raises Price Target to $930

Wells Fargo analyst Dan Leonard maintains Bio-Rad Laboratories (NYSE:BIO) with a Overweight and raises the price target from $735 to $930.